跳至主要内容
临床试验/RPCEC00000373
RPCEC00000373尚未招募3 期

Comparative study of medium-term effects of Palmex (D-004), Saw palmetto,Finasteride and Tamsulosin in patients with Benign prostatic hyperplasia - D4SFTHPB

ational Centre for Scientific Research0 个研究点目标入组 200 人开始时间: 2021年5月27日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
40 years 至 80 years(—)
性别
Male

入选标准

  • Those patients who meet the recruitment criteria (men = 40 years of age who have signed the informed consent and with mild or moderate lower urinary tract symptoms (LUTS). IPSS = 1, <19-) and with prostate enlargement verified by digital rectal examination.

排除标准

  • Patients with
  • Prostate cancer.
  • Previous history of urological surgery (prostate, bladder or urethral).
  • Urinary retention.
  • Prostate antigen (PSA) values> 4 ng / mL.
  • Presence of the middle lobe when performing transrectal ultrasound
  • History of liver failure.
  • History of chronic kidney failure.
  • Blood pressure> 180/110 mmHg.
  • Other active diagnosed neoplasms.
  • Alcoholism.
  • Psychiatric problems that limit the IPSS response.
  • Treatment with ADR-a1 antagonists, 5 a-reductase inhibitors, androgens, antiandrogens, cholinergics, anticholinergics, steroids and /or phytotherapeutic treatments in the 6 months prior to the study.
  • Usual clinical history of allergy to medications or any other special condition that, in the opinion of the doctor, puts your health and life at risk during the study

研究者

发起方
ational Centre for Scientific Research

相似试验